Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

16.60
-1.1500-6.48%
Post-market: 16.600.00000.00%16:10 EDT
Volume:163.00K
Turnover:2.72M
Market Cap:616.59M
PE:-2.24
High:17.65
Open:17.65
Low:16.14
Close:17.75
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:1.01
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.50
PE(LYR):-1.30

Loading ...

Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 02, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 05, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 27, 2022

Major Issues Report

8-K - Current report
Dec 27, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2022

Major Issues Report

8-K - Current report
Oct 07, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 25, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership